Hypertension Diagnostics, Inc.
HDII
$0.00
$0.000.00%
| 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 | |
|---|---|---|---|---|---|
| Net Income | -1,379.06% | 94.18% | -1,589.35% | -871.43% | 102.62% |
| Total Depreciation and Amortization | 21.47% | 4.55% | -11.11% | 5.32% | 25.33% |
| Total Amortization of Deferred Charges | 51.16% | 61.68% | 38.06% | 5.44% | -- |
| Total Other Non-Cash Items | 133.59% | -216.05% | 150.72% | -136.72% | -109.52% |
| Change in Net Operating Assets | 48.45% | -25.68% | -81.93% | 269.74% | -87.35% |
| Cash from Operations | 14.93% | -56.78% | -176.38% | 128.30% | -25.68% |
| Capital Expenditure | -169.81% | -476.79% | -- | 100.00% | 70.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 194.12% | 13.33% |
| Cash from Investing | -53.72% | -476.79% | -108.96% | 232.42% | 77.62% |
| Total Debt Issued | 33.18% | 36.48% | 129.95% | -154.25% | 163.33% |
| Total Debt Repaid | -4.65% | -3.61% | 57.22% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 32.13% | 38.02% | 127.39% | -156.67% | 163.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 106.89% | -3,595.45% | 100.72% | -206.19% | 148.93% |
